Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.
about
International prostate symptom score (IPSS) change and changing factor in intensity-modulated radiotherapy combined with androgen deprivation therapy for prostate cancer.Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicityCurrent concepts in clinical radiation oncology.A clinical review on extreme hypofractionated stereotactic body radiation therapy for localized prostate cancer using nonrobotic linear accelerators.Particle radiotherapy for prostate cancer.Potential applications of image-guided radiotherapy for radiation dose escalation in patients with early stage high-risk prostate cancer.Fiducial marker guided prostate radiotherapy: a review.Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer.Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer.Evaluation of the performance of deformable image registration between planning CT and CBCT images for the pelvic region: comparison between hybrid and intensity-based DIR.Dose-volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-raysLong-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancer.Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy.
P2860
Q36332644-92F29F61-748D-4479-B7A3-D5E654B4FA0EQ36480102-1D587D1B-7024-41FF-87FD-FE13A0D53B80Q37603804-76599AD1-811B-4D99-8BBC-2EE973DA2156Q38198096-8BA0144B-4848-4074-B85F-08781888A7ECQ38259506-7B3DEBE3-C738-4A8D-87BF-6F4FFDDB3636Q38362692-33540501-AB93-4D42-AF60-AD5B0B845C58Q38944077-2D7C6A5F-6D2B-4059-98B1-0D40D7803584Q39375431-406A80A9-5843-4676-BE8B-CA959C72968EQ40026302-A7CEA9BB-2A1B-4292-BF9D-824E0305643DQ41510158-214E6049-974E-4818-BDF4-9038D2293E07Q41546499-66F8C52D-5BE1-4A2E-BC2F-F438FA2F70D1Q41897651-E0396AB6-6F84-45CF-BFC2-C5591675CF45Q47100168-B9EFF53D-95D4-47FA-8827-644E02B9C293
P2860
Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Treatment outcome of high-dose ...... t a single institute in Japan.
@ast
Treatment outcome of high-dose ...... t a single institute in Japan.
@en
type
label
Treatment outcome of high-dose ...... t a single institute in Japan.
@ast
Treatment outcome of high-dose ...... t a single institute in Japan.
@en
prefLabel
Treatment outcome of high-dose ...... t a single institute in Japan.
@ast
Treatment outcome of high-dose ...... t a single institute in Japan.
@en
P2093
P2860
P356
P1433
P1476
Treatment outcome of high-dose ...... t a single institute in Japan.
@en
P2093
Eiji Shimizu
Haruo Matsushita
Kakutaro Narazaki
Keiichi Jingu
Ken Takeda
Koichi Chida
Maiko Kozumi
Masaki Kubozono
Masatoshi Mitsuya
P2860
P2888
P356
10.1186/1748-717X-7-105
P577
2012-07-06T00:00:00Z
P6179
1023626544